Apex on stronger footing; expands pharmaceutical, consumer products


CEO of Apex Healthcare Bhd, Dr Kee Kirk Chin. - Art Chen/ The Star, 10 June 2014.

PETALING JAYA: Apex Healthcare Bhd’s transformation into a healthcare group from a pharmaceutical-based company has put it on a stronger footing in terms of revenue and earnings.

Chairman and chief executive officer Dr Kee Kirk Chin says Apex’s objective is to be an important regional player by growing the pharmaceutical, consumer products and orthopaedics business and increasing its exports.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Business , Corporate News , Apex Pharmacy , earnings , 7090 ,

Next In Business News

MUFG sees ringgit strengthening to 3.70 by end-2026
BMS Holdings stays cautiously optimistic for FY26
PUC receives conditional LFSA approval for Labuan banking licence
P.A. Resources records higher 2Q revenue
Johor Plantations' net profit rises 34%to RM345mil in FY25
DayOne opens Johor training centre, expands KL shared services hub
Betamek’s 3Q profit jumps 90%, declares 1.25 sen dividend
Hextar Industries buys 51% stake in llaollao operator for RM177.5mil
Ringgit hits near eight-year high of 3.89 vs US dollar
Oriental Kopi acquires land in Selangor for RM23mil

Others Also Read